Evidence supporting the use of: Astragalus
For the health condition: Epstein Barr Virus

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Traditional
Rating (out of 5): 2

Astragalus (Astragalus membranaceus) is primarily justified for use against Epstein-Barr Virus (EBV) by traditional use, especially within Traditional Chinese Medicine (TCM). In TCM, astragalus is considered an adaptogen and immune system tonic, historically employed to enhance resistance against infections and support recovery from chronic viral illnesses. The rationale for its use in EBV, the virus responsible for infectious mononucleosis and associated with chronic fatigue, stems from these general immune-boosting properties.

Scientific validation for astragalus's specific efficacy against EBV is limited. Laboratory studies have demonstrated that astragalus extracts can stimulate immune activity, such as increasing the production of interferon and the activity of natural killer (NK) cells and macrophages. These effects could theoretically help the body control viral infections, including EBV, but direct clinical trials evaluating astragalus in patients with EBV infections are lacking. Most studies focus on immune function broadly or on other viral infections (e.g., hepatitis, herpes simplex), rather than EBV specifically.

Thus, while astragalus is traditionally used to support the immune system and has demonstrated general antiviral and immunomodulatory effects in preclinical research, there is insufficient specific clinical evidence to confirm its effectiveness against EBV. Its use for EBV remains rooted in traditional practice rather than robust scientific validation.

More about astragalus
More about Epstein Barr Virus